e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Clinical features of human pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary arterial hypertension in patients with chronic kidney disease on dialysis and without dialysis: Results of the PEPPER-study
S. Pabst, C. Hammerstingl, F. Hundt, T. Gerhardt, C. Grohé, G. Nickenig, R. Woitas, D. Skowasch (Bonn, Berlin, Germany)
Source:
Annual Congress 2011 - Clinical features of human pulmonary hypertension
Session:
Clinical features of human pulmonary hypertension
Session type:
Oral Presentation
Number:
4911
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pabst, C. Hammerstingl, F. Hundt, T. Gerhardt, C. Grohé, G. Nickenig, R. Woitas, D. Skowasch (Bonn, Berlin, Germany). Pulmonary arterial hypertension in patients with chronic kidney disease on dialysis and without dialysis: Results of the PEPPER-study. Eur Respir J 2011; 38: Suppl. 55, 4911
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Pulmonary hypertension in end-stage renal disease and post renal transplantation patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Pulmonary arterial hypertension in the patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 512s
Year: 2005
Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Pulmonary arterial hypertension (PAH) among end state renal disease (ESRD) patients under chronic hemodyalisis (HD)
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Chronic thrombo-embolic pulmonary hypertension: Long-term outcomes in operated and non-operated patients
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
Stroke volume augmentation during exercise in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
Prevalence of pulmonary hypertension in patients undergo hemodialysis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 472
Year: 2011
Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Arterial blood gases during exercise in chronic obstructive pulmonary disease with and without pulmonary hypertension
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012
Arterial hypertension in patients with obstructive lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 417s
Year: 2003
Gender-related differences in pulmonary hemodynamics in patients with end-stage COPD
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011
Predictive factors of arterial stiffness in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept